(TEAM) Atlassian - Overview
Exchange: NASDAQ •
Country: Australia •
Currency: USD •
Type: Common Stock •
ISIN: US0494681010
Stock: Project, Knowledge, Video, Code, Security
Total Rating 19
Risk 28
Buy Signal -1.74
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 60.0% |
| Relative Tail Risk | -9.62% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -2.18 |
| Alpha | -91.12 |
| Character TTM | |
|---|---|
| Beta | 1.432 |
| Beta Downside | 1.440 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.68% |
| CAGR/Max DD | -0.26 |
Description: TEAM Atlassian January 28, 2026
Atlassian Corp (TEAM) delivers a suite of collaboration and development tools-including Jira, Confluence, Bitbucket, Trello, Loom, and its AI layer Rovo-that help organizations coordinate work, manage code, and automate knowledge sharing across teams, positioning the firm as a core enabler of enterprise productivity.
Recent financials show FY 2023 revenue of $3.1 billion, up 23% YoY, with annual recurring revenue (ARR) reaching $4.2 billion-a 30% increase-while operating margin sits around 15% and free cash flow exceeded $400 million. The broader application-software sector is projected to grow at a 12% CAGR through 2026, driven by sustained enterprise IT spend and the shift toward hybrid-work models, both of which reinforce demand for Atlassian’s subscription-based offerings.
For a deeper, data-rich assessment of Atlassian’s valuation dynamics, you may find ValueRay’s analytical platform worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -184.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.25 > 0.02 and ΔFCF/TA -1.35 > 1.0 |
| NWC/Revenue: 13.85% < 20% (prev 9.42%; Δ 4.43% < -1%) |
| CFO/TA 0.26 > 3% & CFO 1.49b > Net Income -184.8m |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (263.0m) vs 12m ago 0.97% < -2% |
| Gross Margin: 82.87% > 18% (prev 0.82%; Δ 8206 % > 0.5%) |
| Asset Turnover: 101.9% > 50% (prev 91.49%; Δ 10.43% > 0%) |
| Interest Coverage Ratio: -2.92 > 6 (EBITDA TTM 694.0k / Interest Expense TTM 31.9m) |
Altman Z'' -2.94
| A: 0.13 (Total Current Assets 3.63b - Total Current Liabilities 2.87b) / Total Assets 5.72b |
| B: -0.79 (Retained Earnings -4.54b / Total Assets 5.72b) |
| C: -0.02 (EBIT TTM -93.2m / Avg Total Assets 5.36b) |
| D: -1.05 (Book Value of Equity -4.55b / Total Liabilities 4.34b) |
| Altman-Z'' Score: -2.94 = D |
Beneish M -3.34
| DSRI: 0.93 (Receivables 536.9m/484.1m, Revenue 5.46b/4.57b) |
| GMI: 0.98 (GM 82.87% / 81.55%) |
| AQI: 0.87 (AQ_t 0.32 / AQ_t-1 0.37) |
| SGI: 1.20 (Revenue 5.46b / 4.57b) |
| TATA: -0.29 (NI -184.8m - CFO 1.49b) / TA 5.72b) |
| Beneish M-Score: -3.34 (Cap -4..+1) = AA |
What is the price of TEAM shares?
As of February 07, 2026, the stock is trading at USD 94.69 with a total of 13,795,353 shares traded.
Over the past week, the price has changed by -19.88%, over one month by -40.21%, over three months by -39.35% and over the past year by -70.32%.
Over the past week, the price has changed by -19.88%, over one month by -40.21%, over three months by -39.35% and over the past year by -70.32%.
Is TEAM a buy, sell or hold?
Atlassian has received a consensus analysts rating of 4.36.
Therefore, it is recommended to buy TEAM.
- StrongBuy: 19
- Buy: 7
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TEAM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 229.6 | 142.5% |
| Analysts Target Price | 229.6 | 142.5% |
| ValueRay Target Price | 75.7 | -20.1% |
TEAM Fundamental Data Overview February 03, 2026
P/E Forward = 24.6914
P/S = 5.6975
P/B = 22.9694
P/EG = 1.2334
Revenue TTM = 5.46b USD
EBIT TTM = -93.2m USD
EBITDA TTM = 694.0k USD
Long Term Debt = 988.1m USD (from longTermDebt, last quarter)
Short Term Debt = 49.0m USD (from shortTermDebt, last quarter)
Debt = 1.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.10b USD (from netDebt column, last quarter)
Enterprise Value = 29.56b USD (31.11b + Debt 1.23b - CCE 2.78b)
Interest Coverage Ratio = -2.92 (Ebit TTM -93.2m / Interest Expense TTM 31.9m)
EV/FCF = 20.49x (Enterprise Value 29.56b / FCF TTM 1.44b)
FCF Yield = 4.88% (FCF TTM 1.44b / Enterprise Value 29.56b)
FCF Margin = 26.41% (FCF TTM 1.44b / Revenue TTM 5.46b)
Net Margin = -3.38% (Net Income TTM -184.8m / Revenue TTM 5.46b)
Gross Margin = 82.87% ((Revenue TTM 5.46b - Cost of Revenue TTM 935.2m) / Revenue TTM)
Gross Margin QoQ = 82.00% (prev 83.07%)
Tobins Q-Ratio = 5.17 (Enterprise Value 29.56b / Total Assets 5.72b)
Interest Expense / Debt = 0.70% (Interest Expense 8.64m / Debt 1.23b)
Taxrate = 21.0% (US default 21%)
NOPAT = -73.6m (EBIT -93.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.26 (Total Current Assets 3.63b / Total Current Liabilities 2.87b)
Debt / Equity = 0.89 (Debt 1.23b / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = -1580 (out of range, set to none) (Net Debt -1.10b / EBITDA 694.0k)
Debt / FCF = -0.76 (Net Debt -1.10b / FCF TTM 1.44b)
Total Stockholder Equity = 1.33b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.45% (Net Income -184.8m / Total Assets 5.72b)
RoE = -13.91% (Net Income TTM -184.8m / Total Stockholder Equity 1.33b)
RoCE = -4.02% (EBIT -93.2m / Capital Employed (Equity 1.33b + L.T.Debt 988.1m))
RoIC = -3.18% (negative operating profit) (NOPAT -73.6m / Invested Capital 2.32b)
WACC = 10.79% (E(31.11b)/V(32.33b) * Re(11.19%) + D(1.23b)/V(32.33b) * Rd(0.70%) * (1-Tc(0.21)))
Discount Rate = 11.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.85%
[DCF Debug] Terminal Value 71.02% ; FCFF base≈1.40b ; Y1≈1.60b ; Y5≈2.22b
Fair Price DCF = 151.8 (EV 24.41b - Net Debt -1.10b = Equity 25.51b / Shares 168.0m; r=10.79% [WACC]; 5y FCF grow 16.95% → 2.90% )
EPS Correlation: 16.93 | EPS CAGR: 21.57% | SUE: 1.25 | # QB: 1
Revenue Correlation: 99.30 | Revenue CAGR: 21.58% | SUE: 1.05 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.34 | Chg30d=+0.001 | Revisions Net=+3 | Analysts=29
EPS current Year (2026-06-30): EPS=4.87 | Chg30d=-0.000 | Revisions Net=+2 | Growth EPS=+32.5% | Growth Revenue=+21.0%
EPS next Year (2027-06-30): EPS=5.63 | Chg30d=-0.011 | Revisions Net=+0 | Growth EPS=+15.5% | Growth Revenue=+18.4%
P/S = 5.6975
P/B = 22.9694
P/EG = 1.2334
Revenue TTM = 5.46b USD
EBIT TTM = -93.2m USD
EBITDA TTM = 694.0k USD
Long Term Debt = 988.1m USD (from longTermDebt, last quarter)
Short Term Debt = 49.0m USD (from shortTermDebt, last quarter)
Debt = 1.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.10b USD (from netDebt column, last quarter)
Enterprise Value = 29.56b USD (31.11b + Debt 1.23b - CCE 2.78b)
Interest Coverage Ratio = -2.92 (Ebit TTM -93.2m / Interest Expense TTM 31.9m)
EV/FCF = 20.49x (Enterprise Value 29.56b / FCF TTM 1.44b)
FCF Yield = 4.88% (FCF TTM 1.44b / Enterprise Value 29.56b)
FCF Margin = 26.41% (FCF TTM 1.44b / Revenue TTM 5.46b)
Net Margin = -3.38% (Net Income TTM -184.8m / Revenue TTM 5.46b)
Gross Margin = 82.87% ((Revenue TTM 5.46b - Cost of Revenue TTM 935.2m) / Revenue TTM)
Gross Margin QoQ = 82.00% (prev 83.07%)
Tobins Q-Ratio = 5.17 (Enterprise Value 29.56b / Total Assets 5.72b)
Interest Expense / Debt = 0.70% (Interest Expense 8.64m / Debt 1.23b)
Taxrate = 21.0% (US default 21%)
NOPAT = -73.6m (EBIT -93.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.26 (Total Current Assets 3.63b / Total Current Liabilities 2.87b)
Debt / Equity = 0.89 (Debt 1.23b / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = -1580 (out of range, set to none) (Net Debt -1.10b / EBITDA 694.0k)
Debt / FCF = -0.76 (Net Debt -1.10b / FCF TTM 1.44b)
Total Stockholder Equity = 1.33b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.45% (Net Income -184.8m / Total Assets 5.72b)
RoE = -13.91% (Net Income TTM -184.8m / Total Stockholder Equity 1.33b)
RoCE = -4.02% (EBIT -93.2m / Capital Employed (Equity 1.33b + L.T.Debt 988.1m))
RoIC = -3.18% (negative operating profit) (NOPAT -73.6m / Invested Capital 2.32b)
WACC = 10.79% (E(31.11b)/V(32.33b) * Re(11.19%) + D(1.23b)/V(32.33b) * Rd(0.70%) * (1-Tc(0.21)))
Discount Rate = 11.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.85%
[DCF Debug] Terminal Value 71.02% ; FCFF base≈1.40b ; Y1≈1.60b ; Y5≈2.22b
Fair Price DCF = 151.8 (EV 24.41b - Net Debt -1.10b = Equity 25.51b / Shares 168.0m; r=10.79% [WACC]; 5y FCF grow 16.95% → 2.90% )
EPS Correlation: 16.93 | EPS CAGR: 21.57% | SUE: 1.25 | # QB: 1
Revenue Correlation: 99.30 | Revenue CAGR: 21.58% | SUE: 1.05 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.34 | Chg30d=+0.001 | Revisions Net=+3 | Analysts=29
EPS current Year (2026-06-30): EPS=4.87 | Chg30d=-0.000 | Revisions Net=+2 | Growth EPS=+32.5% | Growth Revenue=+21.0%
EPS next Year (2027-06-30): EPS=5.63 | Chg30d=-0.011 | Revisions Net=+0 | Growth EPS=+15.5% | Growth Revenue=+18.4%